Jian-xian Lin

Fujian Medical University

Papers

2

Total Citations

45

H-Index

2

About

Jian-xian Lin is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for gastric cancer treatment, with a particular emphasis on robotic surgery. His most impactful work, a randomized phase 2 trial comparing robotic versus laparoscopic distal gastrectomy (2024, 42 citations), provides critical evidence that robotic surgery is a safe and effective alternative to conventional laparoscopy for resectable gastric cancer. This study addresses a significant gap in the literature by offering the first randomized controlled data on survival outcomes between these approaches. Lin has further extended this investigation to vulnerable populations, as demonstrated in his multicenter cohort study on elderly patients (2025), evaluating both short- and long-term outcomes. His contributions are shaping the evolution of gastric cancer surgery by rigorously assessing the benefits of robotic platforms—including potential improvements in lymph node dissection and recovery times—while maintaining oncologic safety. Through these high-impact clinical trials and cohort analyses, Lin is helping to define the optimal surgical strategies for different patient subgroups, ultimately improving outcomes for those facing gastric cancer.

Research Focus

Key Achievements

2
H-Index
2
Papers
45
Total Citations
23
Avg Citations/Paper
🏆 Most Cited Paper
Robotic versus laparoscopic distal gastrectomy for resectable gastric cancer: a randomized phase 2 trial
42 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 32
🏛 Institutions: Fujian Medical University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago